|
US725511A
(en)
*
|
1902-10-07 |
1903-04-14 |
John Thomson Press Company |
Apparatus for securing ink-distributing cylinders to platen printing-press.
|
|
US3639385A
(en)
*
|
1968-07-26 |
1972-02-01 |
Eastman Kodak Co |
Heterocyclic monoazo compounds from n n-diaralkyl anilines and polyester textile materials dyed therewith
|
|
US4181803A
(en)
*
|
1973-12-14 |
1980-01-01 |
Eisai Co., Ltd. |
Propiophenone derivatives and preparation thereof
|
|
ATE25078T1
(de)
*
|
1982-10-27 |
1987-02-15 |
Degussa |
2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung.
|
|
DE3337593A1
(de)
|
1982-10-27 |
1984-05-03 |
Degussa Ag, 6000 Frankfurt |
2-amino-3-acylamino-6-benzylamino-pyridin-derivate mit antiepileptischer wirkung
|
|
ATE46265T1
(de)
|
1985-01-23 |
1989-09-15 |
Asta Pharma Ag |
Synergistische kombination von flupirtin und nicht-steroidalen antiphlogistika.
|
|
DE3604575A1
(de)
|
1985-02-23 |
1986-08-28 |
Degussa Ag, 6000 Frankfurt |
Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
|
|
EP0193056B1
(de)
*
|
1985-02-23 |
1989-06-07 |
ASTA Pharma Aktiengesellschaft |
Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
|
|
JP2583067B2
(ja)
*
|
1987-08-04 |
1997-02-19 |
住友化学工業株式会社 |
モノアゾ化合物およびそれを用いて疎水性繊維材料を染色または捺染する方法
|
|
GB8800199D0
(en)
*
|
1988-01-06 |
1988-02-10 |
Beecham Group Plc |
Pharmaceutical preparation
|
|
MC2029A1
(fr)
|
1988-05-16 |
1990-04-25 |
Asta Pharma Ag |
(n-heterocyclyl)-3 diamino-2,6 pyridines substituees et leurs n-oxydes,preparation de ces composes et leur application comme medicaments
|
|
US5629307A
(en)
*
|
1989-10-20 |
1997-05-13 |
Olney; John W. |
Use of ibogaine in reducing excitotoxic brain damage
|
|
US6004945A
(en)
*
|
1990-05-10 |
1999-12-21 |
Fukunaga; Atsuo F. |
Use of adenosine compounds to relieve pain
|
|
IN172468B
(enExample)
*
|
1990-07-14 |
1993-08-14 |
Asta Medica Ag |
|
|
US5643921A
(en)
*
|
1990-09-26 |
1997-07-01 |
E.R. Squibb & Sons, Inc. |
Cardiopulmonary bypass and organ transplant using a potassium channel activator
|
|
US5234947A
(en)
*
|
1991-11-07 |
1993-08-10 |
New York University |
Potassium channel activating compounds and methods of use thereof
|
|
DE4200259A1
(de)
*
|
1992-01-08 |
1993-07-15 |
Asta Medica Ag |
Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
|
|
US5262419A
(en)
*
|
1992-06-11 |
1993-11-16 |
E. R. Squibb & Sons, Inc. |
Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
|
|
CA2115792C
(en)
*
|
1993-03-05 |
2005-11-01 |
David J. Mayer |
Method for the treatment of pain
|
|
US5428039A
(en)
*
|
1994-02-20 |
1995-06-27 |
The Center For Innovative Technology |
Method for electively achieving reversible hyperpolarized cardiac arrest
|
|
WO1996009044A1
(en)
*
|
1994-09-22 |
1996-03-28 |
Richard Alan Smith |
Compositions useful for the preparation of medicines for treating a variety of intractable disorders
|
|
US5679706A
(en)
*
|
1994-09-30 |
1997-10-21 |
Bristol-Myers Squibb Company |
Combination of a potassium channel activator and an antiarrhythmic agent
|
|
MX9703988A
(es)
*
|
1994-12-12 |
1998-02-28 |
Omeros Med Sys Inc |
SOLUCIaN Y MÉTODO DE IRRIGACIaN PARA LA INHIBICIaN DEL DOLOR, LA INFLAMACIaN Y ES ESPASMO.
|
|
DE19539861A1
(de)
*
|
1995-10-26 |
1997-04-30 |
Asta Medica Ag |
Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
|
|
DE19701694A1
(de)
*
|
1997-01-20 |
1998-07-23 |
Asta Medica Ag |
Neue Modifikationen des 2-Amino-4-(4-fluorbenzylamino)-l-ethoxycarbonyl-aminobenzen sowie Verfahren zu ihrer Herstellung
|
|
US5760007A
(en)
*
|
1997-07-16 |
1998-06-02 |
Ortho Pharmaceutical Corporation |
Anticonvulsant derivatives useful in treating neuropathic pain
|
|
ES2251095T3
(es)
*
|
1997-08-08 |
2006-04-16 |
Chugai Seiyaku Kabushiki Kaisha |
Agentes terapeuticos para complicaciones diabeticas.
|
|
US6265417B1
(en)
*
|
1997-12-18 |
2001-07-24 |
Abbott Laboratories |
Potassium channel openers
|
|
US6593335B1
(en)
*
|
1997-12-18 |
2003-07-15 |
Abbott Laboratories |
Potassium channel openers
|
|
US6211171B1
(en)
*
|
1998-05-19 |
2001-04-03 |
Dalhousie University |
Use of antidepressants for local analgesia
|
|
JP3441970B2
(ja)
|
1998-06-30 |
2003-09-02 |
株式会社サミー |
豆腐の製造方法及び製造装置
|
|
JP2000143510A
(ja)
|
1998-11-16 |
2000-05-23 |
Taisho Pharmaceut Co Ltd |
外用組成物
|
|
IL143726A0
(en)
*
|
1998-12-14 |
2002-04-21 |
Cellegy Pharma Inc |
A pharmaceutical composition containing a nitric oxide donor
|
|
US6281211B1
(en)
*
|
1999-02-04 |
2001-08-28 |
Euro-Celtique S.A. |
Substituted semicarbazides and the use thereof
|
|
GB9903476D0
(en)
*
|
1999-02-17 |
1999-04-07 |
Zeneca Ltd |
Therapeutic agents
|
|
CA2359485A1
(en)
*
|
1999-03-10 |
2000-09-14 |
Warner-Lambert Company |
Analgesic compositions comprising anti-epileptic compounds and methods of using same
|
|
WO2000055137A1
(en)
|
1999-03-17 |
2000-09-21 |
Signal Pharmaceuticals, Inc. |
Compounds and methods for modulation of estrogen receptors
|
|
AT409083B
(de)
*
|
1999-04-01 |
2002-05-27 |
Sanochemia Pharmazeutika Ag |
Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
|
|
US6610324B2
(en)
|
1999-04-07 |
2003-08-26 |
The Mclean Hospital Corporation |
Flupirtine in the treatment of fibromyalgia and related conditions
|
|
GB9915414D0
(en)
|
1999-07-01 |
1999-09-01 |
Glaxo Group Ltd |
Medical use
|
|
MXPA01012726A
(es)
|
1999-07-06 |
2002-07-02 |
Lilly Co Eli |
Antagonistas selectivos del receptor de iglur5 para el tratamiento de la migrana.
|
|
US6472165B1
(en)
|
1999-08-03 |
2002-10-29 |
Arzneimittelwerk Dresden Gmbh |
Modulatory binding site in potassium channels for screening and finding new active ingredients
|
|
DE60037321T4
(de)
*
|
1999-08-04 |
2010-01-07 |
Icagen, Inc. |
Benzanilide als öffner des kaliumkanals
|
|
US6495550B2
(en)
*
|
1999-08-04 |
2002-12-17 |
Icagen, Inc. |
Pyridine-substituted benzanilides as potassium ion channel openers
|
|
AU772075B2
(en)
*
|
1999-08-04 |
2004-04-08 |
Icagen, Inc. |
Methods for treating or preventing pain and anxiety
|
|
US6117900A
(en)
*
|
1999-09-27 |
2000-09-12 |
Asta Medica Aktiengesellschaft |
Use of retigabine for the treatment of neuropathic pain
|
|
US6383511B1
(en)
*
|
1999-10-25 |
2002-05-07 |
Epicept Corporation |
Local prevention or amelioration of pain from surgically closed wounds
|
|
US6538004B2
(en)
*
|
2000-03-03 |
2003-03-25 |
Abbott Laboratories |
Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
|
|
US20020015730A1
(en)
*
|
2000-03-09 |
2002-02-07 |
Torsten Hoffmann |
Pharmaceutical formulations and method for making
|
|
US6348486B1
(en)
*
|
2000-10-17 |
2002-02-19 |
American Home Products Corporation |
Methods for modulating bladder function
|
|
US6589986B2
(en)
*
|
2000-12-20 |
2003-07-08 |
Wyeth |
Methods of treating anxiety disorders
|
|
US6469042B1
(en)
*
|
2001-02-20 |
2002-10-22 |
Bristol-Myers Squibb Company |
Fluoro oxindole derivatives as modulators if KCNQ potassium channels
|
|
AR033095A1
(es)
*
|
2001-04-04 |
2003-12-03 |
Wyeth Corp |
Metodos para el tratamiento de motilidad gastrica hiperactiva
|
|
GB0121214D0
(en)
|
2001-08-31 |
2001-10-24 |
Btg Int Ltd |
Synthetic method
|
|
AU2003202115A1
(en)
|
2002-02-12 |
2003-09-04 |
Pfizer Inc. |
Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
|
|
WO2003097586A1
(en)
|
2002-05-17 |
2003-11-27 |
Janssen Pharmaceutica N.V. |
Aminotetralin-derived urea modulators of vanilloid vr1 receptor
|
|
WO2003106454A1
(en)
|
2002-06-12 |
2003-12-24 |
Orchid Chemicals & Pharmaceuticals Ltd |
1h-isoquinoline-oxazolidinone derivaties and their use as antibacterial agents
|
|
AUPS312602A0
(en)
*
|
2002-06-21 |
2002-07-18 |
James Cook University |
Organ arrest, protection, preservation and recovery
|
|
US7419981B2
(en)
*
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
|
AU2003294441A1
(en)
*
|
2002-11-22 |
2004-06-18 |
Bristol-Myers Squibb Company |
1-aryl-2-hydroxyethyl amides as potassium channel openers
|
|
EP1585522B1
(en)
*
|
2002-12-23 |
2010-11-17 |
Icagen, Inc. |
Quinazolinones as potassium channel modulators
|
|
JP2006515300A
(ja)
|
2002-12-27 |
2006-05-25 |
ハー・ルンドベック・アクチエゼルスカベット |
中枢神経系の疾患の治療に有用な１，２，４−トリアミノベンゼン誘導体
|
|
EP1606247A1
(en)
|
2003-03-14 |
2005-12-21 |
H. Lundbeck A/S |
Substituted aniline derivatives
|
|
BRPI0408437A
(pt)
|
2003-03-21 |
2006-04-04 |
Lundbeck & Co As H |
derivados de p-diaminobenzeno substituìdos, composição farmacêutica, e, uso da mesma
|
|
US20060264496A1
(en)
|
2003-04-25 |
2006-11-23 |
H. Lundbeck A/S |
Substituted indoline and indole derivatives
|
|
AU2004243444A1
(en)
|
2003-05-27 |
2004-12-09 |
Altana Pharma Ag |
Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility
|
|
US20050070570A1
(en)
*
|
2003-06-18 |
2005-03-31 |
4Sc Ag |
Novel potassium channels modulators
|
|
EP1663239A4
(en)
*
|
2003-09-10 |
2008-07-23 |
Cedars Sinai Medical Center |
KALIUM CHANNEL-MEDIATED FEEDING OF MEDICINES BY THE BLOOD BRAIN BARRIER
|
|
US7799832B2
(en)
*
|
2003-10-23 |
2010-09-21 |
Valeant Pharmaceuticals North America |
Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
|
|
DE10359335A1
(de)
|
2003-10-23 |
2005-05-25 |
Viatris Gmbh & Co. Kg |
Kombinationen aus Kaliumkanalöffnern und Natriumkanalinhibitoren oder Natriumkanal beeinflussenden Wirkstoffen zur Behandlung von Schmerzzuständen
|
|
ES2235626B1
(es)
|
2003-11-10 |
2006-11-01 |
Almirall Prodesfarma, S.A. |
Formas de administracion masticables, no comprimidas dosificadas individualmente.
|
|
TWI349666B
(en)
|
2004-03-12 |
2011-10-01 |
Lundbeck & Co As H |
Substituted morpholine and thiomorpholine derivatives
|
|
RU2006139933A
(ru)
|
2004-04-13 |
2008-05-20 |
Икаген, Инк. (Us) |
Полициклические пиридины как модуляторы калиевых ионных каналов
|
|
WO2005110405A1
(en)
*
|
2004-05-03 |
2005-11-24 |
Duke University |
Compositions for affecting weight loss
|
|
UA89503C2
(uk)
|
2004-09-13 |
2010-02-10 |
Х. Луннбек А/С |
Заміщені похідні аніліну
|
|
EP1813285A4
(en)
|
2004-11-19 |
2010-06-09 |
Kissei Pharmaceutical |
PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST NEUROPATHIC PAIN
|
|
EP1688141A1
(en)
*
|
2005-01-31 |
2006-08-09 |
elbion AG |
The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
|
|
PL2298766T3
(pl)
|
2005-03-03 |
2014-09-30 |
H Lundbeck As |
Preparaty farmaceutyczne zawierające podstawione pochodne pirydyny
|
|
US7683058B2
(en)
*
|
2005-09-09 |
2010-03-23 |
H. Lundbeck A/S |
Substituted pyrimidine derivatives
|
|
MX2009002002A
(es)
|
2006-08-23 |
2009-07-22 |
Valeant Pharmaceuticals Int |
Derivados de 4-(n-azacicloalquil) anilidas como moduladores de canal de potasio.
|
|
US8030518B2
(en)
|
2006-11-28 |
2011-10-04 |
Valeant Pharmaceuticals International |
1,4 diamino bicyclic retigabine analogues as potassium channel modulators
|